M. Sextro

2.5k total citations · 1 hit paper
10 papers, 1.5k citations indexed

About

M. Sextro is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, M. Sextro has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in M. Sextro's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). M. Sextro is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). M. Sextro collaborates with scholars based in Germany, Italy and Finland. M. Sextro's co-authors include Volker Diehl, Dirk Hasenclever, Hartmut Kirchner, Norbert Schmitz, Peter E. Müller, Beate Pfistner, Anthony H. Goldstone, Markus Sieber, Bettina Koch and Andreas Lohri and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

M. Sextro

10 papers receiving 1.5k citations

Hit Papers

Aggressive conventional chemotherapy compared with high-d... 2002 2026 2010 2018 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
    2002 755 citations Norbert Schmitz, Beate Pfistner et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Sextro Germany 9 1.3k 943 567 388 244 10 1.5k
Monica Balzarotti Italy 23 1.2k 0.9× 699 0.7× 545 1.0× 402 1.0× 365 1.5× 69 1.5k
FB Hagemeister United States 11 1.1k 0.8× 704 0.7× 324 0.6× 391 1.0× 193 0.8× 18 1.3k
F. Boissevain Germany 7 1.0k 0.8× 655 0.7× 467 0.8× 235 0.6× 283 1.2× 8 1.2k
G. Taghipour United Kingdom 15 1.2k 0.9× 799 0.8× 405 0.7× 431 1.1× 164 0.7× 22 1.4k
Liliana Devizzi Italy 22 1.5k 1.1× 960 1.0× 456 0.8× 478 1.2× 376 1.5× 59 1.9k
P. Solal-Céligny France 8 1.2k 0.9× 818 0.9× 389 0.7× 539 1.4× 131 0.5× 14 1.5k
C. Portlock United States 21 1.1k 0.8× 732 0.8× 261 0.5× 438 1.1× 367 1.5× 36 1.6k
D. J. Moir United Kingdom 10 781 0.6× 540 0.6× 320 0.6× 258 0.7× 159 0.7× 11 1.1k
Sophie Lefort France 6 994 0.8× 698 0.7× 283 0.5× 352 0.9× 97 0.4× 10 1.3k
Nicholas Voss Canada 16 823 0.6× 512 0.5× 399 0.7× 289 0.7× 160 0.7× 37 1.1k

Countries citing papers authored by M. Sextro

Since Specialization
Citations

This map shows the geographic impact of M. Sextro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sextro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sextro more than expected).

Fields of papers citing papers by M. Sextro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sextro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sextro. The network helps show where M. Sextro may publish in the future.

Co-authorship network of co-authors of M. Sextro

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sextro. A scholar is included among the top collaborators of M. Sextro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sextro. M. Sextro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schmitz, Norbert, Beate Pfistner, M. Sextro, et al.. (2002). Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. The Lancet. 359(9323). 2065–2071. 755 indexed citations breakdown →
2.
Pfreundschuh, Michael, Dirk Hasenclever, Markus Loeffler, et al.. (2001). Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF. Annals of Oncology. 12(4). 471–477. 10 indexed citations
3.
Bohlen, Heribert, Marcus M. Kessler, M. Sextro, Volker Diehl, & Hans Tesch. (2000). Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels. Annals of Hematology. 79(3). 110–113. 82 indexed citations
4.
Lieberz, D., M. Sextro, U. Paulus, et al.. (2000). How to restrict liver biopsy to high-risk patients in early-stage Hodgkin's disease. Annals of Hematology. 79(2). 73–78. 7 indexed citations
5.
6.
7.
Loeffler, Markus, Oana Brosteanu, Dirk Hasenclever, et al.. (1998). Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.. Journal of Clinical Oncology. 16(3). 818–829. 143 indexed citations
8.
Wasielewski, R von, Martin Werner, R. Fischer, et al.. (1997). Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.. PubMed. 150(3). 793–803. 55 indexed citations
9.
Sextro, M., et al.. (1996). Lymphocyte predominant Hodgkin's disease — a workshop report. Annals of Oncology. 7. S61–S65. 19 indexed citations
10.
Hasenclever, Dirk & M. Sextro. (1996). Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks.. PubMed. 17 Suppl 2. S28–30. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Balzarotti Breakdown of academic impact, for papers by FB Hagemeister Breakdown of academic impact, for papers by F. Boissevain Breakdown of academic impact, for papers by G. Taghipour Breakdown of academic impact, for papers by Liliana Devizzi Breakdown of academic impact, for papers by P. Solal-Céligny Breakdown of academic impact, for papers by C. Portlock Breakdown of academic impact, for papers by D. J. Moir Breakdown of academic impact, for papers by Sophie Lefort Breakdown of academic impact, for papers by Nicholas Voss
Rankless by CCL
2026